added ibrutinib in first-line cll treatment
Published 6 years ago • 617 plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
6:47
ibrutinib venetoclax for first-line treatment of chronic lymphocytic leukaemia (cll)/small lym...
-
6:55
ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia
-
4:04
ibrutinib plus venetoclax for the first-line treatment of cll/sll: results from the captivate study
-
4:59
comparing outcomes of first-line ibrutinib vs chemoimmunotherapy in high-risk cll
-
11:23
captivate: fixed-duration first-line treatment with ibrutinib plus venetoclax for cll/sll
-
7:36
fixed-duration ibrutinib and venetoclax for first-line cll
-
10:41
captivate: first-line ibrutinib plus venetoclax for cll/sll
-
8:13
ash 2015: ibrutinib as first-line treatment for chronic lymphocytic leukaemia
-
1:13
5-year follow-up of patients with cll treated in first-line with ibrutinib plus venetoclax
-
1:31
can ibrutinib be used as a first-line treatment in cll?
-
2:18
first-line ibrutinib and venetoclax in cll
-
3:22
treatment strategies with ibrutinib in cll
-
1:43
dr shadman on dose reductions with ibrutinib in real-world cll
-
1:56
ibrutinib plus venetoclax for first-line treatment of cll: 4-year follow-up data
-
2:43
outcomes in high-risk cll patients following fixed-duration treatment with ibrutinib plus venetoclax
-
4:12
positive long-term data of ibrutinib venetoclax as first-line cll treatment
-
1:38
front-line use of ibrutinib for cll in a real-world setting
-
1:47
ianalumab add-on therapy in cll patients receiving ibrutinib
-
0:39
dr. byrd on ibrutinib in cll